INTRODUCTION
Enterococci are a frequent cause of a wide variety of infections in humans (54, 66, 167, 186) . These organisms most commonly infect the urinary tract (59, 65, 72, 92, 99, 144, 165) , bloodstream (22, 65, 90, 93, 152, 154, 189, 194, 227) , endocardium (62) , abdomen (9, 32, 52, 83, 90, 152, 204) , biliary tract (134, 152) , burn wounds (130, 152) , and indwelling foreign devices (such as intravascular catheters [90, 152, 188] ). Although enterococci can infect the central nervous system (12) , lung (17, 21, 90, 152, 186) , soft tissues (109) , paranasal sinuses (53, 152) , ear (186) , eye (211) , and periodontal tissue (86) , these infections occur less frequently. Enterococcus faecalis causes 80 to 90% of human enterococcal infections, while E. faecium accounts for a majority of the remainder (162, 167, 192) . Other enterococcal species, including E. avium (181) , E. casseliflavus (183) , E. durans, E. gallinarum, E. hirae, E. malodoratus, E. mundtii (131) , E. raffinosus (38) , and E. solitarius, are infrequent causes of human infection (67, 192) .
In the 1970s and 1980s enterococci became firmly established as major nosocomial pathogens. They are now the b Transferable beta-hemolysin active against horse erythrocytes; similarity to prototype pADl-encoded cytolysin cyl not defined (37) . c LD50, 50% lethal dose (quantity of organisms lethal for 50% of inoculated animals).
d Presumptive producer of aggregation substance; EDTA-sensitive clumping activity suggestive of pheromone responsiveness; specific clump-inducing pheromone and aggregation substance not determined (37) .
e Most, if not all, gram-positive organisms express lipoteichoic acids as cell wall components. f ND, not determined. Activity may be known; however, the factor has not yet been tested in an in vivo and/or in vitro infection model. come increasingly apparent in recent years, enterococci express factors that permit adherence to host cells and extracellular matrix, facilitate tissue invasion, effect immunomodulation, and cause toxin-mediated damage. This review discusses enterococcal traits with the potential to contribute to virulence. Increases in enterococcal infections, especially in the hospital, associated with the emergence and proliferation of multi-drug-resistant strains require a careful reexamination of mechanisms that enterococci use to initiate or exacerbate infection. Descriptions of enterococcal infections, their management, and resistance to antibiotics are mentioned here only when relevant to virulence. For information on these topics, readers are instead referred to several recent reviews (5, 62, 63, 103, 146, 152, 162, 167, 182) . After a brief overview of selected historical perspectives, this review discusses the current understanding of enterococcal virulence relating to (i) adherence to host tissues, (ii) invasion and abscess formation, (iii) factors potentially relevant to modulation of host inflammatory responses, and (iv) potentially toxic secreted products. A summary of several of these factors can be found in Table 1 .
HISTORICAL PERSPECTIVE
The first examination of enterococcal virulence was reported in 1899 (151) , the same year the organism was discovered (216) . MacCallum and Hastings (151) (151) . Koch's postulates were fully satisfied when endocarditis was reproduced by using the organism in a canine model (151) .
The first systematic study of the properties of an enterococcal virulence factor was the study of cytolysin or hemolysin by Todd in 1934 (218) . He observed that although some strains of E. faecalis produced discernible zones of hemolysis on blood agar plates, "... this group failed to produce haemolytic filtrates when grown in Hewitt's broth" (218) . Although he called these strains "pseudo-hemolytic," cytolytic activity was detected by using a "horse flesh infusion" medium (218) . We find this infusion, modified by substitution of ground beef for less readily obtainable horse flesh, to be superior to commercially available media for production of cytolysin in liquid culture, although only modest cytolytic activity is produced (83a). The basis for production in some media and not others is unclear and is the subject of ongoing studies on cytolysin expression.
Cytolysin production by E. faecalis is recognized by the development of clearing around colonies on certain blood agar media. This E. faecalis phenotype, however, frequently has been overlooked in clinical microbiology laboratories because sheep erythrocytes, the target cells commonly used in blood agar plates, are refractory to cytolysin-mediated lysis (11, 136) .
Erythrocytes from rabbits, humans, horses, and cows are readily lysed by the E. faecalis cytolysin (11, 136) and should be used instead to identify this phenotype. The more general term cytolysin is preferred over the historical term hemolysin be-VOL. 7, 1994 cause, as discussed below, the target cell range is broad and includes eukaryotic and prokaryotic cells. Cytolysin production by E. faecalis was formerly a criterion for classification as Streptococcus zymogenes (24) or, later, Streptococcus faecalis var. zymogenes (25) . The finding that cytolysin was transmissible by plasmids (57, 123) , and therefore was a variable trait, coupled with data provided by numerical taxonomic studies placing all E. faecalis variants into one cluster (26, 128) caused the zymogenes designation to be abandoned (166) .
Other secreted products long associated with enterococci, but less well studied, are hyaluronidase (191) and protease (or gelatinase) (3, 151, 202) . In 1955, Schultz-Haudt and Scherp postulated that the initial lesion in periodontal disease may be disruption of intercellular cementing substances of the epithelium as a result of mucopolysaccharidase (or hyaluronidase) activity (199) . This effect was predominantly ascribed to strains of Streptococcus mitis and Streptococcus salivarius. Hyaluronidase-producing enterococci were subsequently described by Rosan and Williams in studies of microorganisms causing periodontal disease (191) . The contribution of this enzyme to periodontal disease has not been further investigated, even though enterococci are commonly isolated from periodontal infections (75, 132, 174) and were shown in 1955 to readily induce dental caries formation in monoassociated rats infected with a nonproteolytic strain (180) .
E. faecalis strains with protease activity were once referred to as E. faecalis var. liquefaciens (202) . Strains with this designation have been used in animal models of enterococcal infection (94, 105, 151 ), but, as described below, few studies have specifically tested the contribution of protease to this process.
The inability of enterococci to cause chronic or severe infections in laboratory animals after inoculation into subcutaneous tissue or the peritoneal cavity has been used to support arguments for the relative nonvirulence of enterococci. Hite et al. (105) , however, reported in 1949 that enterococci caused necrotizing abscess formation in the abdominal walls of mice when mixed with nonsporulating anaerobic bacteria. These investigators went on to note that enterococci mixed with heat-killed anaerobes continued to promote abscess formation, although heat-treated enterococci did not augment the virulence of live anaerobes (105) . These remarkable observations have been confirmed by others (30, 157, 159, 178) , as discussed below, but the mechanism by which this microbial synergism occurred remains unexplained.
Although urinary tract infections are commonly caused by enterococci, few studies have explored the predisposition of enterococci for this site. Guze et al. (94) were the first to carefully characterize hematogenous infection of the kidney by enterococci. In a rat model, using an unmanipulated urinary tract, these workers consistently produced chronic, progressive enterococcal pyelonephritis through a single intravenous inoculation (94) . Histologically, infection at 2 days appeared as focal medullary abscesses. Over 1 week, extensive progression of focal radial cellular infiltrates to the renal cortex occurred (94, 148) . Bacteruria invariably developed in 2 to 3 days but only after microabscesses appeared in the renal parenchyma.
ENTEROCOCCAL GENETIC EXCHANGE Plasmid-and transposon-encoded genes, besides those necessary for replication and transfer, typically confer traits that provide survival advantages to organisms in unusual environments (58 (42, 195) . At least three conjugative systems exist by which enterococci naturally transfer genetic elements. First, narrow-hostrange, pheromone-responsive plasmids unique to enterococci have been described (43) . These plasmids transfer at high frequencies on solid surfaces, in broth, and in vivo (43, 112) . Second, many plasmids with a broad host range (e.g., pAMB1) readily transfer at low frequency among enterococci, Streptococcus spp., Staphylococcus aureus, Lactobacillus spp., Bacillus subtilis, and other species (42, 195) . Coexisting pheromoneresponsive plasmids can greatly increase the transfer frequency of these plasmids (43) . Transfer requires contact between donor and recipient cells on a solid surface and can occur in vivo (164) . Finally, conjugative gene exchange occurs through highly promiscuous transposons found in gram-positive and gram-negative bacteria (200) . One transposon, Tn1545, has been shown to transfer at low frequency from E. faecalis to Listeria monocytogenes in the intestinal tracts of gnotobiotic mice (51) . Tn916 is the most thoroughly characterized conjugative transposon and has been used extensively in molecular genetic studies (76, 200) .
The only other known mechanism of natural gene exchange for enterococci is through infection with bacteriophages (35, 173) . Enterococcal bacteriophages have been isolated from stool (190) and have a narrow host range rendering them of potential use for strain typing (138) . The ability of enterococcal bacteriophages to spread virulence traits or antibiotic resistance determinants is largely unknown.
ADHERENCE TO HOST TISSUES
Bacterial adherence to host tissues is a crucial first step in the infection process (8) . For gastrointestinal commensals such as enterococci, adhesins that promote binding to eukaryotic receptors on mucosal surfaces would be expected to play a critical role in maintenance of colonization. Without specific means of attachment, enterococci would likely be eliminated by bulk flow of luminal contents through normal intestinal motility. Adherence through surface-exposed adhesins to epithelial cells, endothelial cells, leukocytes, or extracellular matrix is generally a first step in infection. Adhesin systems have been described for several pathogens, including Escherichia coli, Kiebsiella pneumoniae, Haemophilus influenzae, Yersinia pseudotuberculosis, Bordetella pertussis, Streptococcus pyogenes, and Streptococcus sanguis (20, 102, 106, 127, 141) . These adhesins have been shown to play diverse roles as effector molecules leading to phagocytosis, inciting or reducing local inflammatory responses, or acting as toxins. Only recently have enterococcal adhesins been investigated.
Exogenous Acquisition of Enterococci
For many years infection-derived enterococci were believed to arise endogenously from a patient's own flora (133) . Recent clinical studies, however, have demonstrated that enterococci and enterococcal plasmids transfer between patients (23, 39, 111, 113, 149, 168, 170, 187, 235, 239, 243, 244) . Clones of enterococci have also been reported to cause outbreaks of infection and become endemic in hospitals for months to years (23, 39, 111, 113, 149, 168, 170, 187, 235, 239, 243, 244) . The development of simple and precise methods to identify enterococcal strains (98, 169, 245) along with emergence of increasingly antibiotic-resistant strains have, in part, been a catalyst for these studies. One theme noted in many studies has been use of parenteral antibiotics without significant antienterococcal activity in patients preceding the development of an enterococcal infection.
These observations suggest that select exogenous enterococcal strains have heightened capabilities to colonize, overgrow, invade host tissues, and persist compared with endogenous enterococcal flora. Examples of factors conferring such traits might include E. faecalis cytolysin or AS-48 peptide. Both are potent bacteriocins (80, 122) that may confer selective advantages for growth on exogenous strains compared with endogenous strains without these phenotypes. In hospitalized patients receiving antibiotics that reduce the resistance of the gastrointestinal tract to microbial colonization (224) , endogenous enterococcal flora may be supplanted through selective action of such bacteriocin-producing hospital strains. Alternatively, endogenous flora could acquire these phenotypes through plasmid transfer, as has been demonstrated to occur in the gastrointestinal tracts of hamsters (112) . Studies to test these suppositions are in progress. Other enterococcal determinants potentially important to colonization or overgrowth are discussed below.
Aggregation Substance Aggregation substance is a surface-bound protein encoded by pheromone-responsive plasmids of E. faecalis and expressed in response to pheromone induction (55) . Aggregation substance converts the surface of the donor bacterium into one adherent to potential recipient cells, causing aggregation or clumping and facilitating transfer of plasmids (55) . Transposon insertional mutagenesis has localized the aggregation substance gene on pAD1 to a position 9.4 kb from the origin ( Fig.  la) (60) . Nucleotide sequence determination for this gene, asal, revealed two Arg-Gly-Asp motifs, similar to those initially reported for fibronectin (241) and capable of binding eukaryotic cell receptors termed integrins (78) .
Aggregation substance appears to be anchored in the bacterial membrane by its C terminus in a manner common to cell wall-associated proteins of gram-positive bacteria (171) . In electron micrographs, aggregation substance is a hair-like structure incorporated into old cell wall (225) . Genes encoding aggregation substance from a variety of cytolysin-specifying and non-cytolysin-specifying, pheromone-responsive plasmids are highly conserved (79, 104) . The deposition pattern of aggregation substance encoded by the pheromone-responsive plasmid pCF10, when cloned and constitutively expressed from the construction pINY1801, is shown at high resolution in Fig.  2 (177) . In addition to facilitating exchange of plasmids carrying virulence traits and antibiotic resistance genes, aggregation substance may augment enterococcal adherence to intestinal and renal epithelial cells (137) and cardiac vegetations (40) . These subjects are further discussed below in sections on translocation, urinary tract infection, and endocarditis, respectively.
Surface Carbohydrates
Evidence indicating the existence of carbohydrate adhesins for enterococci was first reported by Guzm'an et al. (95, 96) . This group observed that E. faecalis strains isolated from urinary tract infections adhered efficiently to urinary tract epithelial cells in vitro (95) . In contrast, E. faecalis strains isolated from the blood of patients with endocarditis adhered efficiently to the Girardi Heart human cell line (95) . When urinary tract isolates were grown in the presence of serum, adherence to the heart cell line was enhanced. In vitro competitive inhibition assays using D-mannose, D-glucose, Lfucose, and D-galactose implicated enterococcal surface carbohydrates in binding bacteria to cells in culture (96) . Carbohydrate-mediated adherence of E. faecalis to different substrates was described as complex and mediated by several adhesins. Indeed, some adhesins were present in all strains and under all growth conditions, while others were expressed only after growth in human serum. Guzman et al. proposed lipoteichoic acid as a likely candidate for anchoring these carbohydrate moieties to the cell, but the identity of these adhesins has yet to be determined.
Other Adherence Mechanisms In contrast to detailed characterizations of aggregation substance, limited information is available on other factors promoting adhesion of enterococci to host tissues. Shorrock and Lambert investigated the binding of fibronectin and albumin by E. faecalis (205) . They found that fibronectin bound E. faecalis with higher affinity than albumin did. Treatment of E. faecalis with protease or periodate reduced binding, suggesting a surface receptor comprising protein and/or carbohydrate components. Lipoteichoic acid did not interfere with binding, implying that this molecule was not an adhesin for fibronectin as it is for S. pyogenes (206) . The relevance of fibronectin binding to E. faecalis is discussed further below in the section on endocarditis.
INVASION OF HOST TISSUES Bacteremia and Translocation
Enterococci are currently the third leading cause of nosocomial bacteremia in the United States (65) . While many cases are due to identifiable sources, such as intravenous lines, abscesses, and urinary tract infection, a large percentage remain obscure in origin (90, 140) and presumably originate from the intestinal tract (1, 234 (1, 224, 234) . Some parenteral antibiotics with little antienterococcal activity, such as cephalosporins, are known to cause a predisposition to enterococcal superinfection (129, 161, 242) and are consistently associated with development of enterococcal bacteremia (6, 90, 93, 113, 175, 243, 244 (85, 117) . cylA encodes the cytolysin activator (201) . The Immunogold-labeled aggregation substance. Anti-AsclO monoclonal antibody was used to label aggregation substance expressed on the surface of OGlRF(pINY1801) cells. Antibody specifically bound to aggregation substance was in turn labeled with 12-nm colloidal gold-tagged secondary antibody. From reference 177 with permission of the publisher. models of catheter-induced endocarditis (7) . Vegetations on heart valves in experimental endocarditis are composed primarily of fibrin, platelets, and fibronectin (196) . Bacterial or yeast adherence to fibronectin in particular correlates well (but not perfectly) with the propensity of microorganisms to cause endocarditis (139, 196) . Animal models have been used extensively to define therapies for enterococcal endocarditis (34, 36, 69, 107, 121, 135, 213, 215, 217, 226, 240) , but these models have been used less frequently to investigate enterorcoccal determinants important to this infection process.
Several investigators have compared the abilities of microorganisms to adhere to endocardial vegetations. Crawford and Russell (48) examined streptococci from patients with subacute bacterial endocarditis and found that E. faecalis strains were less adherent than strains of S. aureus and Streptococcus pyogenes but more adherent than strains of S. mutans, S. milleri, S. sanguis, S. mitior, or S. salivarius. Although no correlation was found between adherence of strains to fibrin-platelet clots and their ability to cause endocarditis, the authors hypothesized that specific adhesion mechanisms may increase the risk for endocarditis but may not be the most important trait for expression of pathogenicity (48) . In contrast, Scheld et al. (196) found that E. faecalis bound fibronectin better than gramnegative bacilli but not as well as S. aureus or pathogenic Candida species. In a rabbit model of catheter-induced endocarditis, the log1o 50% infective dose for E. faecalis was only 1.4 times higher than that for S. aureus (196) .
The seminal investigation of enterococcal microbial determinants in a model of catheter-induced endocarditis was conducted by Chow et al. (40) . Three isogenic E. faecalis strains which expressed cytolysin and aggregation substance, cytolysin alone, or aggregation substance alone were compared with a plasmid-free strain for the ability to cause endocarditis. These researchers determined for rabbits with endocarditis the masses and bacterial counts of cardiac vegetations and mortality at 3 days. Rabbits infected with strains expressing aggregation substance exhibited vegetations of increased weight regardless of cytolysin phenotype (40) . Although larger vegetations were noted for rabbits infected with noncytolytic E. faecalis strains expressing aggregation substance, these strains were no more virulent than the plasmid-free strain with respect to mortality (40) . The mortality for rabbits infected with strains producing only aggregation substance or cytolysin was significantly lower than that for animals infected with the strain expressing aggregation substance and cytolysin (7 versus 55%). The 50% infective doses for these strains were not determined, so it is not known whether aggregation substance augments infectivity of E. faecalis in this model. Further research will determine how frequently cytolysin-producing and aggregation substance-encoding E. faecalis strains cause endocarditis in humans and whether a higher morbidity or mortality is associated with this phenotype.
Abscess and Soft Tissue Infection
The ability of enterococci to infect in pure culture soft tissues or the peritoneum of animals (or humans) is limited (30, 105, 178) . Hite et al. (105) , however, showed nearly 50 years ago that enterococci could produce severe soft tissue infection when mixed with otherwise avirulent anaerobic microorganisms. These observations fit clinical experience, since pure enterococcal infections are rare at these sites. The concept of microbial synergy is also supported by antimicrobial regimens that lack activity against enterococci but are effective in treating mixed enterococcal infections of soft tissue and peritoneum (10, 237) .
Using animal models, Onderdonk et al. (178) and others (30, 157, 159) have confirmed Hite's findings. Onderdonk et al. (178) used a rat model of intraabdominal sepsis and determined that abscesses consistently formed only when combinations of an anaerobe and a facultative microorganism, such as E. coli or an enterococcus, were used. In the study of Matlow et al. (159) , intraperitoneal inoculation of rats with E. faecalis in combination with E. coli, Bacteroidesfragilis, and Clostridium perfringens was more often associated with death or large abscess formation than similar inocula without E. faecalis. Curiously, these investigators were able to recover E. faecalis from 33% of abscesses when E. faecalis had not been in the original inoculation. Similarly, Martens et al. (157) observed that nearly one-third of bacteria recovered from experimental pelvic abscesses in female rats had not been part of the original inoculum. Both groups speculated that this phenomenon resulted from translocation of organisms across the bowel wall.
Although microbial synergy between enterococci and anaerobes is well established (30, 105, 157, 159, 178) , the mechanism has not been aggressively studied. Possibly encapsulation of anaerobic organisms plays a role (31, 179) . Whether other metabolic, toxin-mediated, or immunomodulatory factors contribute to the interplay between anaerobes, enterococci, and host immune cells remains open to further study.
Urinary Tract Infection
The bladder, prostate, and kidney are commonly infected by enterococci, especially in patients with structural abnormalities of the urinary tract or indwelling catheters (72, 144, 165 (13) noted that enterococcal lipoteichoic acid reversibly bound human erythrocytes as well as lipoteichoic acid from S. pyogenes. The acyl moiety of lipoteichoic acid was essential for binding (13) . Lipoteichoic acid is continually released from S. pyogenes independent of stage of growth cycle (2) . Whether enterococci also release lipoteichoic acid is not known. These facts may be relevant to a local inflammatory process, because lipoteichoic acid bound by eukaryotic cells retains antigenic specificity. As a result, these cells can suffer complementmediated lysis when exposed to plasma (110) . Conceivably, tissue damage at sites of infection could arise from activation of complement by host cell membrane-associated bacterial lipoteichoic acid (110) .
Bhakdi and coworkers tested the ability of lipoteichoic acids from clinically important gram-positive organisms to stimulate production of interleukin-l,B, interleukin-6, and tumor necrosis factor alpha from cultured human monocytes (18) . Interestingly, they observed that lipoteichoic acids from S. aureus and S. pneumoniae failed to induce monokine production, while lipoteichoic acids from several enterococcal species at concentrations ranging from 0.5 to 5.0 ,ug/ml induced release of all three monokines. The levels of monokines stimulated by enterococcal lipoteichoic acid were similar to those observed after exposure to gram-negative lipopolysaccharides. Similarly, Tsutsui et al. (221) found enterococcal lipoteichoic acid to be a potent inducer of tumor necrosis factor and interferon.
Finally, Ehrenfeld et al. (61) reported that purified lipoteichoic acid from E. faecalis inhibited pheromone-induced aggregation of bacterial cells. They suggested that lipoteichoic acid acted as the binding substance recognized by aggregation substance on donor cells. Analysis of genes affecting binding substance has proven complex and is in progress (16, 220) . Together these studies suggest that enterococcal lipoteichoic acid may serve as a virulence factor by modulating inflammatory responses and through facilitation of plasmid transfer.
Complement and Neutrophils
Only recently have interactions between complement, human neutrophils, and enterococci been examined (4, 100, 176) . Two groups investigating E. faecalis and E. faecium reported opsonization of both by the alternative complement pathway (4, 100). Harvey et al. (100) found enhanced neutrophil killing of enterococci in the presence of complement and specific rabbit antienterococcal immune globulin. Arduino et al. (4) , however, reported no augmentation of neutrophil killing by antienterococcal hyperimmune rabbit serum. Rather, they suggested that neutrophil killing depended primarily on complement activation and not specific immune globulin (4) . Strains capable of expressing protease, cytolysin, or aggregation substance proved no more resistant to phagocytosis than strains lacking these phenotypes (4) . Whether these strains actually expressed protease, cytolysin, or aggregation sub-CLIN. MICROBIOL. REV. stance under the in vitro assay conditions employed was not demonstrated.
The ease with which enterococci are opsonized is consistent with their apparent lack of capsular polysaccharide. These studies also suggest that enterococci lack significant antiphagocytic determinants. However, pathogens phagocytosed by neutrophils rarely survive exposure to hypohalous acids resulting from a respiratory burst. Macrophages are less efficient in killing ingested pathogens than neutrophils, in part because they lack myeloperoxidase and cannot produce hypohalous acids from reactive oxygen species. Several gram-positive organisms, such as S. aureus and N. asteroides, can catalyze superoxide and hydrogen peroxide found in phagolysosomes to improve their chances of survival (14, 155) . Although enterococci are catalase negative, they express a flavin containing NADH peroxidase to degrade hydrogen peroxide (184) . Enterococci also possess an oxygen-inducible superoxide dismutase to catalyze conversion of superoxide to hydrogen peroxide (27, 91) . Whether these enzymes enhance survival of enterococci after phagocytosis by macrophages awaits investigation.
Pheromones
Pheromones are small peptides seven to eight amino acids in length secreted by E. faecalis that promote conjugative transfer of plasmid DNA between strains (43, 115) . These peptides are chromosomally encoded and are referred to as pheromones because they elicit a specific mating response from plasmidcarrying donor cells. Typically, multiple pheromones are secreted simultaneously by a given E. faecalis strain. In addition to pheromones, each pheromone-responsive plasmid encodes a secreted peptide that acts as a competitive inhibitor of its corresponding pheromone. Recent reports suggest that some, but not all, pheromones and their peptide inhibitors possess the potential to serve additional roles as chemoattractants for neutrophils, cause granule enzyme secretion, and induce a respiratory burst (64) . This last effect may explain the augmentation of neutrophil superoxide production observed by Novak et al. (176) when E. faecalis strains containing a conjugative, cytolytic plasmid were phagocytosed. Although pheromones and their inhibitors are nonformylated oligopeptides, they competitively inhibit formyl-Met-Leu-Phe binding to the neutrophil formyl peptide receptor and appear to act as a ligand for this surface receptor (193) .
Pheromones cAM373 and cPD1 were reported by Sannomiya et al. (193) to be chemoattractants at nanomolar concentrations. Ember and Hugli (64), however, noted activities 2 to 3 orders of magnitude lower for the same pheromones when slightly different assay conditions were used. In either case, these pheromone concentrations are 2 to 3 orders of magnitude greater than those found in enterococcal culture supernatants (45) . Although E. faecalis strains typically secrete multiple pheromones (45) , and chemotactic effects of pheromones appear to be additive at low concentrations (64), the question of whether these peptides or their inhibitors significantly modulate inflammatory responses in vivo remains unanswered. Indeed, formylmethionyl peptides derived from amino-terminal regions of newly synthesized proteins in prokaryotic organisms also serve as chemoattractants for neutrophils (156, 160) . Conversely, cell wall components can be antagonistic to leukocyte migration (172) and inducers of inflammation (33) . Whether any of these molecules, or complement components such as CSa which would be expected at sites of infection, are more or less important as immunomodulators in vivo is in need of further investigation.
SECRETED PRODUCTS Cytolysin
Generally, the cytolytic phenotype is specified by highly conserved, transmissible plasmids (57, 120, 142) . Initially, cytolysin-encoding plasmids were found to belong to the same IncHly incompatibility group (46) . However, cytolytic plasmids from other incompatibility groups have been reported (116) . Moreover, cytolysin genes occasionally occur as chromosomal elements (116) . The most extensively characterized cytolysinencoding plasmid is pAD1 (43) .
In 1949 Sherwood et al. (203) reported on five of eight beta-hemolytic group D streptococci that inhibited growth of other bacteria. These observations were extended by Stark (209) in 1960, when each of 16 beta-hemolytic E. faecalis strains was found to inhibit growth of most gram-positive, but no gram-negative, bacteria. Brock et al. (29) subsequently examined nearly 100 enterococcal isolates and found that over 50% expressed a bacteriocin activity. Cytolytic E. faecalis strains expressed a bacteriocin with broad activity against gram-positive, but not gram-negative, bacteria (29) . These investigators also demonstrated that cytolytic and bacteriolytic activities were simultaneously lost by some E. faecalis strains after exposure to UV irradiation and that these activities were simultaneously regained by reversion (28) . This coincident behavior provided strong evidence for a single enterococcal product being responsible for cytolytic and bacteriolytic activities (28) .
Several studies by Granato and Jackson in the late 1960s and early 1970s provided convincing data that the E. faecalis cytolysin was at least bicomponent in nature (87) (88) (89) . These investigators termed the two operationally defined components L for lysin, and A for activator, on the basis of the kinetics of interaction (87) . Transposon insertional mutation localized the cytolysin determinant on pAD1 to 8 kb of DNA ( Fig. la) (44, 60, 117) . These studies permitted direct cloning of restriction fragments related to cytolysin expression and ultimately reassembly of a functional cytolysin expression unit in E. coli (117) .
Nucleotide sequence determination for the E. faecalis cytolysin operon has revealed a complex determinant encoding five gene products (Fig. lb) (84, 85, 201) . Several lines of evidence suggest that the E. faecalis cytolysin represents a new branch of the lantibiotic family, a group of small secreted proteins with bactericidal activity against gram-positive pathogens such as staphylococci, streptococci, and propionibacteria (198) . Reading frames cylLl, cylL2, cyIM, and cyIB are relevant to expression of component L (84, 85, 117) , whereas cylA is the only reading frame necessary for expression of component A (201) .
Analysis of cylA revealed an inferred extracellular protein with similarity to the serine protease subtilisin BPN' (201) . These findings were supported by physical and biochemical evidence and suggested that CylA activates cytolysin precursors extracellularly by protein cleavage (201) .
Expression of component L has proven to be considerably more complex than that of CylA. It involves at least two cytolysin precursor peptides and two auxiliary factors (85) . Nucleotide sequence determination has revealed two small open reading frames, termed cylLI and cylL2, at the extreme 5' end of the cytolysin operon (85, 117) . From nucleotide sequence analysis, both CylLl and CylL2 are inferred to be small, relatively cystine-rich polypeptides. The amino-terminal halves are relatively hydrophilic and are followed by distinctly hydrophobic carboxyl termini (85) . A current model of the cytolysin operon suggests that these peptides are the ribosomally synthesized precursors of cytolysin (Fig. 3) . Site-specific VOL. 7, 1994 CLIN. MICROBIOL. REV. mutagenesis in each reading frame demonstrated that CylLl and CylL2 were both required for expression of cytolysin (85) .
A large reading frame encoding a 993-amino-acid polypeptide and termed cylM was found adjacent to and immediately 3' to the cylLl and cylL2 reading frames (Fig. lb) (85) . The carboxy-terminal half of CyiM has amino acid sequence similarity with analogs occurring in operons related to expression of nisin, epidermin, and subtilin (85) . Each of these cell membrane-active peptides is a lantibiotic (198) . These peptides are unusual in that posttranslational modifications of serines, threonines, and cysteines form thioether-bridged lanthionines (198, 210 ). CylM appears to be an intracellular protein that participates in the posttranslational modifications of CylLl and CylL2, which may include introduction of lanthionine or methyllanthionine cross-links as occurs in maturation of other lantibiotics (41, 75, 197, 198) . Site-specific mutations in cyiM block expression of functional CylLl and CylL2, indicating that both depend on the cyIM gene product for maturation (85) . Studies to analyze the structures of and interaction between activated CylLl and CylL2 are ongoing.
Immediately 3' to cyIM is an open reading frame termed cyIB (Fig. lb) . cyIB was the first gene encoding an ATP-binding cassette transporter reported for a gram-positive bacterium (84) . ATP-binding cassette transporters are transmembrane systems that facilitate translocation of molecules with a high degree of substrate specificity and contain highly conserved ATP-binding motifs (70) . CylB is most closely related to ATP-binding cassette transporters identified in nisin and subtilin operons (70 (85) . Expression of CylA is not affected by mutations in cyIB (84) .
A model of E. faecalis cytolysin activation based on these observations is shown in Fig. 3 . This model also incorporates observations on how cytolysin-producing E. faecalis cells resist self-lysis. Since CylA is a serine protease, immunity appears to result in part from additional proteolytic cleavage of CylLl and CylL2 close to the cell, beyond that required for activation. Transformation of cytolysin-susceptible E. faecalis cells with DNA containing the cylA reading frame renders them cytolysin resistant (201) . Moreover, addition of culture fluid containing excessive CylA to a cytolysin assay results in reduction of cytolysin activity (87, 117) . Thus, CylA appears to play a dual role in activating cytolysin and simultaneously conferring immunity to it. There is some evidence suggesting that a portion of CylA produced by wild-type cytolytic E. faecalis remains associated with the cell surface (201) . This association may ensure a protective level of CylA in the microenvironment of cytolysin-producing cells. The structural basis for CylA association with the cell wall remains to be established.
The proposed model for cytolysin activation is limited in several respects. It fails to address additional phenotypic traits that may positively or negatively affect cytolysin activity. For example, superoxide production by E. faecalis also contributes 470 JETr ET AL. to erythrocyte lysis (27, 68 (99, 120) , and were found to be clonally related (99, 111) . In one study, cytolytic strains were determined by regression analysis to be associated with a fivefold-increased risk for death within 3 weeks of bacteremia compared with patients with bacteremia caused by noncytolytic strains (113) .
Animal models have been used to demonstrate and quantify the contribution of cytolysin to enterococcal virulence. With mice, Ike and Clewell (119) observed a direct, dose-dependent correlation between cytolysin expression and the toxicity of E. faecalis after intraperitoneal injection. In this study, the 50% lethal dose was greater than 3 x 109 CFU for an E. faecalis strain harboring a plasmid with blocked expression of cytolysin. After 7 days, no mouse injected with this strain died. In contrast, a lower 50% lethal dose of 2.6 x 108 CFU was found for an isogenic strain expressing wild-type levels of cytolysin.
All mice injected with -109 CFU of this strain died within 4 to 5 h. An even slightly lower 50% lethal dose of 1.6 x 108 CFU was observed for a third strain harboring an isogenic plasmid overexpressing cytolysin. All mice injected with .3 x 108 CFU of this strain died within 1 to 2 h (119).
In another comparison of isogenic strains attenuated only in cytolysin expression, Jett et al. (126, 211) Su et al. (212) subsequently reported the sequence of the protease gene, gelE, which encoded a prezymogen with a mature molecular weight of 34,582. Protease production was easily detected by these investigators using semisolid media supplemented with 3% gelatin or 1.5% skim milk (47, 212) .
A potential contribution of enterococcal protease to virulence was first suggested in 1975 by Gold et al. (86) , who found that a gelatin-liquefying human oral E. faecalis isolate, 2SaR (later designated OG1 [56] ), induced caries formation in germfree rats, while nonproteolytic strains did not. In addition, others have linked protease production to human infection. Kuhnen et al. (138) reported protease-producing E. faecalis to be common among enterococci (63.7%) isolated from surgical and neurosurgical intensive care units in Germany. Coque et al. (47) analyzed 95 enterococcal isolates from patients with endocarditis and other nosocomial infections and found that 54% produced protease. In this same study, only 12 and 14% of enterococcal isolates from uninfected hospitalized patients and healthy volunteers, respectively, produced protease.
Although epidemiologic studies can only suggest associations between protease production and infection, the sequence analysis of gelE showed tantalizing amino acid similarity to the 33-kDa zinc-metalloproteinase (elastase) of Pseudomonas aeruginosa (77, 212) . This enzyme is considered a virulence factor in severe Pseudomonas infections, especially for patients with cystic fibrosis (50, 223) . A recent review of bacterial zinc-metalloproteases describes the medical importance of these common enzymes (101) . Cloning of gelE and its introduction and expression in a protease-negative enterococcal strain (212) should permit direct testing of its contribution to infection.
Hyaluronidase
Studies of hyaluronidase in other microorganisms have provided an indirect basis for speculating that this enzyme contributes to enterococcal virulence. Detection of hyaluronidase production by microorganisms is accomplished by inoculation of semisolid media containing hyaluronic acid (114, 207) . Unsworth (222) observed hyaluronidase-producing Streptococcus milleri strains from abscesses more frequently (83%) than strains that were part of the normal flora (25%). Pneumococcal hyaluronidase appeared to play a role in one animal model of middle ear inflammation (150) . In addition, it has been described as a spreading factor for Ancylostoma duodenale (hookworm) in cutaneous larva migrans (108) and as important for the dissemination of Treponema pallidum (74) . These precedents suggest that enterococcal hyaluronidase VOL. 7, 1994 could play a role in invasive disease. No studies, however, address this issue for enterococci.
AS-48
AS-48 is a 7.4-kDa peptide produced by E. faecalis that inhibits and lyses a wide spectrum of gram-negative and gram-positive bacteria, including enterococci (80) . This basic peptide is lytic via the generation of pores in cytoplasmic membranes of target cells that lead to depolarization (81) . It also appears to induce lysis of selected enterococci through activation of an autolysin (82) . As with the cytolysin operon, AS-48 has been found to be encoded by a transmissible plasmid (158) . The (230) . Extracellular toxins such as cytolysin can induce tissue damage as shown in the endophthalmitis model (124, 211) , increase mortality in combination with aggregation substance in an endocarditis model (40) , and cause systemic toxicity in a murine peritonitis model (119) . Finally, lipoteichoic acid, superoxide production, or pheromones and corresponding peptide inhibitors each may modulate local inflammatory reactions.
The recent interest in enterococcal virulence and hostparasite interaction has been spurred on, in part, by concerns that increasing antibiotic resistance may soon render conventional chemotherapy inadequate for serious enterococcal infections. As our understanding of enterococcal pathogenic mechanisms evolves, so too must our ability to prevent and limit the consequences of these infections and to counter the spread of antibiotic resistance. Much work has been done, but the challenge remains formidable.
